Family-owned Kent Pharmaceutical Holdings sold in £58m deal
by Trevor Sturgess
A family-owned drugs firm has been sold in a £58 million
deal.
Kent Pharmaceuticals Holdings Limited (KPHL), based in Orbital
Park, Ashford, is now part of DCC Healthcare after its acquisition
by its DCC Vital subsidiary.
Kent law firm Brachers played a key role the transaction,
advising the majority shareholders in one of the largest deals
handled by the firm in 2012.
Kent Pharmaceuticals is a family business set up in the early
1980s. It went on to become Britain’s largest independent generic
pharmaceuticals manufacturer and leading wholesaler.
It is involved in the development, manufacture, sales, marketing
and distribution of generic products for the British, Irish and
international markets.
It offers more than 100 own label products, with a manufacturing
plant in Ireland supplying the UK with some 60% of the total
penicillin antibiotics sold.
DCC Vital, a healthcare services business, provides sales,
marketing and distribution services in Ireland and Britain to
healthcare providers, medical and pharmaceutical brand owners and
manufacturers. DCC Plc is based in Ireland with a workforce of
9,000.
DCC plans to combine the Kent business to create a
pharmaceuticals business with combined turnover of around £123
million. A spokesman said there were plans for expansion which
could involve more jobs.
Mike Overy, KPHL chairman, is staying on. He said: “The
shareholders believe this transaction provides a fantastic
opportunity to continue the growth and development of KPHL with a
partner that is committed to expanding in the generic
pharmaceutical market both locally and internationally.”
He paid tribute to the Brachers' team led by corporate partners
James Bullock and Philip Cunningham.
“We could not have achieved it without the hard work and
expertise of the corporate team at Brachers," he said.
"We needed a legal team that can negotiate at the highest level
and under great pressure, Brachers delivered."
Mr Bullock said: “Brachers has a long-standing relationship with
the shareholders of Kent Pharmaceuticals.
"This is a fantastic deal for them and the county as a whole: a
Kent business that has grown from scratch to a multi-million pound
business that is now part of a major international group with plans
to invest heavily in the business."
14/01/13
- Click here for more Ashford news...
- Click here for more news from across the county...